Abstract
Health communication addressing the public, whether in the context of doctor-patient interrelation, through interactions of focal groups or via mass communication, should always have the ethical commitment of communication, in the most suitable form, of the “truth” or, at least, the scientifi c verisimilitude (in the updated state of the art) concerning health promotion, whether in the form of prevention, medical treatment or cure of diseases. From this standpoint, how to make sense out of the “placebo effect” whose goal is also to alleviate human suffering caused by the loss of health, hut now based on the fi ction (from the hegemonic medicine perspective) which is its very essence? This article aims at describing some aspects of the actual scientifi c understanding of this “effect”, exploring its nature, typical traits, limitation and possibilities in health promotion under an ethical but also pragmatic perspective. Several present explanations are mentioned concerning this “effect”: the psychological one (conditioned refl ex), the anthropological one (through descriptions of magical and curative procedures in so called “primitive” cultures), the psycho-neuro-physiological bases of the placebo-nocebo phenomenon, etc. Besides, we deal with the some of the diffi culties that the “placebo effect” causes in double-blind trials (to determine the real effi cacy of new medicines in the treatment of certain diseases).
References
2. Barsky AJ, Saintfort R, Rogers MP, Borus JF. Nonspecifi c Medication Side Effects and the Nocebo Phenomenon. JAMA 2002; 287:622-627.
3. Belfort R, Schor P. Programas inteligentes, inteligência artifi cial e oftalmologia. Arq. Bras. Oftalmol. 2000 Aug; 63(4).
4. Cho HJ, Hotopf M, Wessely S. The placebo response in the treatment of chronic fatigue syndrome: a systematic review and meta-analysis. Psychosom Med. 2005;67:301-13.
5. Collins H, Pinch T. Dr. Golem: How to think about medicine. Chicago: University of Chicago Press; 2005.
6. Enserink M. Are Placebo-Controlled Drug Trials Ethical. Science. 2000 April; 288(5465): 416.
7. Epstein I. Informação e desinformação em medicina. Boletim Intercom 1982 Novembro/Dezembro (40): 25-28.
8. Epstein I. Nocebo e os eventuais efeitos adversos dos medicamentos relatados nas bulas. In: Melo JM, Epstein I, Gobbi MC, Gomes ALZ, organizadores. Mídia, Mediação e Medicalização: Anais da VI Conferência Brasileira de Comunicação e Saúde; 2003 out. 1-3; São Paulo, Brasil. Brasília: Anvisa; 2005.
9. Epstein I, organizador. A Comunicação também cura na relação entre médico e paciente. São Paulo. Angellara; 2006. 10. Ilnycky JA, Greenberg H, Bernstein CN. Quantifi cation of the placebo response in ulcerative colitis. Gastroenterology. 1997;112:1854-8.
11. Kuhn T. Revoluções Científi cas. São Paulo: Perspectiva; 1978.
12. Lakoff A. Managing the Placebo effect in Antidpressant Trials. MI. 2000 April; (2): 72-76.
13. Levi-Strauss C. Antropologia Estrutural. Rio de Janeiro: Biblioteca do Tempo Universitário; 1967.
14. Macedo A, Banos JE, Farré M. Placebo response in the prophylaxis of migraine: a meta-analysis. Eur Journal of Pain 2008; 12:68-75.
15. Mauss M. Sociologia e Antropologia. São Paulo: Edusp; 1974.
16. Patel SM, Stason WB, Legedza A, Ock SM, Kaptchuk TJ, Conboy L, et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterology Motil 2005; 17: 332-40.
17. Petrovic P, Kalso E, Peterson KM, Ingvar M. Placebo and Opioid Analgesia- Imaging a Shared Neuronal Network. Science 2002 March; 295 (5560): 1737-1740.
18. Philipon P. L’ effet placebo. La Recherché. 2003 JuilletAoût; (366): 54-57.
19. Popper K. La lógica de la investigación científi ca. Madrid; 1967.
20. Price DD, Finniss DQ, Benedetti F. Comprehensive of the Placebo Effect: Recent advances and Current Thought. Annuan Review of Psychology. 1998; 59: 565-590.
21. Quitkin FM, McGrath PJ, Stewart JW. Placebo run-in period in studies of depressive disorders, Clinical, heuristic and research implications. Brit, Journal Psychiatry. 1998; 173: 242-248.
22. Suc C, Lichtenstein GR, Krok K, Brensinger CM, Lewis JD. A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn disease. Gastroenterology. 2004;126:1257-69
23. Sysko R, Walsh BT. A systematic review of placebo response in studies of bipolar mania. Journal of Clin Psychiatry. 2007 Aug; 68(8):1213-7.
24. Walsh BT, Seidman SN, Sysko. R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA. 2002;287:1840-7.
25. Zulian Teixeira M. Bases psiconeurológicas do fenômeno placebo-nocebo: evidências científi cas que valorizam a relação médico-paciente. Revista da Associação Médica Brasileira. 2001;55(1):13-18
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2010 Isaac Epstein